Xabier Agirre

Pamplona, NC, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications

Multiple myeloma: A tale of deregulated transcription factors.

Multiple myeloma: A tale of deregulated transcription factors.

Journal: HemaSphere
Published: February 19, 2026

Deacetylase inhibitors CM-444 and CM-1758 enhance chemotherapy response in AML via ALOX5.

Deacetylase inhibitors CM-444 and CM-1758 enhance chemotherapy response in AML via ALOX5.

Journal: British journal of haematology
Published: December 16, 2025

Beyond synthetic lethality in large-scale metabolic and regulatory network models via genetic minimal intervention set.

Beyond synthetic lethality in large-scale metabolic and regulatory network models via genetic minimal intervention set.

Journal: Bioinformatics advances
Published: September 01, 2025

"Linc-ing" RNA isoforms to function in multiple myeloma.

"Linc-ing" RNA isoforms to function in multiple myeloma.

Journal: Blood
Published: August 14, 2025

Stromal and endothelial transcriptional changes during progression from MGUS to myeloma and after treatment response.

Stromal and endothelial transcriptional changes during progression from MGUS to myeloma and after treatment response.

Journal: Nature communications
Published: July 12, 2025

IRF2 is an Essential Transcription Factor with Pathogenic and Prognostic Impact in Multiple Myeloma.

IRF2 is an Essential Transcription Factor with Pathogenic and Prognostic Impact in Multiple Myeloma.

Journal: Blood
Published: April 01, 2025

IRF2 is an essential transcription factor with pathogenic and prognostic impact in multiple myeloma.

IRF2 is an essential transcription factor with pathogenic and prognostic impact in multiple myeloma.

Journal: Blood
Published: April 01, 2025

Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma.

Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma.

Journal: Blood
Published: October 30, 2024

BET inhibitors downregulate the expression of the essential lncRNA SMILO in multiple myeloma through regulation of the transcription factor FLI1.

BET inhibitors downregulate the expression of the essential lncRNA SMILO in multiple myeloma through regulation of the transcription factor FLI1.

Journal: Haematologica
Published: May 29, 2024

Single-Nucleotide Polymorphisms in WNT Genes in Patients with Non-Syndromic Orofacial Clefts in a Polish Population.

Single-Nucleotide Polymorphisms in WNT Genes in Patients with Non-Syndromic Orofacial Clefts in a Polish Population.

Journal: Diagnostics (Basel, Switzerland)
Published: May 28, 2024

PVR (CD155) epigenetic status mediates immunotherapy response in multiple myeloma.

PVR (CD155) epigenetic status mediates immunotherapy response in multiple myeloma.

Journal: Leukemia
Published: May 10, 2024

HDACi vorinostat protects muscle from degeneration after acute rotator cuff injury in mice.

HDACi vorinostat protects muscle from degeneration after acute rotator cuff injury in mice.

Journal: Bone & joint research
Published: April 15, 2024
Showing 1-12 of 100

Last Updated: 09/26/2026